NEW YORK, Dec. 10, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Global Clinical Nutrition Products Industry
http://www.reportlinker.com/p01375125/Global-Clinical-Nutrition-Products-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pharmaceutical
This report analyzes the worldwide markets for Clinical Nutrition Products in US$ Million by the following Product Segments: Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East/Africa, and Latin America. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.
The report profiles 68 companies including many key and niche players such as -
Abbott Laboratories, Inc.
Abbott Nutrition
Ajinomoto Co., Inc.
American HomePatient, Inc.
Baxter International, Inc.
B. Braun Melsungen AG
Claris Lifesciences Ltd.
Groupe Danone
Nutricia North America
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONSStudy Reliability and Reporting Limitations I-1Disclaimers I-2Data Interpretation & Reporting Level I-2Quantitative Techniques & Analytics I-3Product Definitions and Scope of Study I-31. Enteral Nutrition I-32. Infant Nutrition I-43. Parenteral Nutrition I-4II. EXECUTIVE SUMMARY
1. INDUSTRY OVERVIEW II-1
A Bird's Eye View of the Clinical Nutrition Products Market II-1
Emerging Markets: The New Hotspots for Growth II-2
Infant Nutrition: The Largest & Fastest Growing Category II-2
Impact of Healthcare Budget Cuts: A Review II-3
Table 1: Healthcare Spending as a Percentage of GDP in Select
Countries (includes corresponding Graph/Chart) II-4
Competitive Landscape II-5
Table 2: Leading Players in the Global Clinical Nutrition
Market (2012): Percentage Breakdown of Value Sales for Abbott
Laboratories, Nestle, Fresenius Kabi, Danone, B. Braun,
Baxter International and Others (includes corresponding
Graph/Chart) II-6
Enteral Nutrition Market II-7
Table 3: Leading Players in the Global Enteral Nutrition
Market (2012): Percentage Breakdown of Value Sales for
Abbott, Nestle, Danone, Fresenius and Others (includes
corresponding Graph/Chart) II-7
Infant Nutrition Market II-7
Table 4: Leading Players in the Global Infant Nutrition
Market (2012): Percentage Share Breakdown of Value Sales for
Nestlé S.A, Danone, Mead Johnson Nutrition, Abbott, Heinz and
Others (includes corresponding Graph/Chart) II-7
Global Parenteral Nutrition Market II-8
Table 5: Leading Players in the Global Parenteral Nutrition
Market (2012): Percentage Share Breakdown of Value Sales for
Baxter International, Fresenius Kabi, B.Braun, Hospira and
Others (includes corresponding Graph/Chart) II-8
2. MARKET DRIVERS, TRENDS & ISSUES II-9Ageing Population: A Strong Growth Driver II-9Table 6: Elderly Population (65+ Years) as a Percentage ofthe Total Population: 2000 & 2025 (includes correspondingGraph/Chart) II-10
Table 7: Global Population Statistics for the 65+ Age Group
(2012) (includes corresponding Graph/Chart) II-11
Rising Incidence of Chronic Diseases to Kindle Market Growth
in Clinical Nutrition Products Market II-12
World Cancer Statistics: Incidence and Mortality Data II-12
Table 8: World Cancer Incidence by Geographic Region and
Gender (2012): Number of New Cancer Cases Reported (in
Thousands) for Asia-Oceania, Europe, North America, Latin
America & the Caribbean, and Africa (includes corresponding
Graph/Chart) II-13
Table 9: World Cancer Mortality by Geographic Region andGender (2012): Number of Cancer-Related Deaths (inThousands) for Asia-Oceania, Europe, North America, LatinAmerica & the Caribbean, and Africa (includes correspondingGraph/Chart) II-14
Table 10: New Cancer Cases in the World by Affected Site
(2012) (In Thousands) (includes corresponding Graph/Chart) II-15
Table 11: Global Incidence of Common Cancers in Men (2012):Number of New Cases Reported in Thousands for Lung &Bronchus, Prostate, Colorectal and Liver Cancers (includescorresponding Graph/Chart) II-16
Table 12: Global Incidence of Common Cancers in Women
(2012): Number of New Cases Reported in Thousands for
Breast, Colorectal, Lung & Bronchus and Liver Cancers
(includes corresponding Graph/Chart) II-16
Table 13: Global Cancer Mortality in Men for Select Cancers(2012): Number of Deaths in Thousands for Lung & Bronchus,Liver, Colorectal and Prostate Cancers (includescorresponding Graph/Chart) II-17
Table 14: Global Cancer Mortality in Women for Select
Cancers (2012): Number of Deaths in Thousands for Breast,
Lung & Bronchus, Colorectal and Liver (includes
corresponding Graph/Chart) II-17
Cancer Prone Sites based on Age II-17
Diabetes Mellitus: Another Key Chronic Disease II-17
Table 15: Worldwide Prevalence of Diabetes Mellitus by
Region: 2012 & 2030 (includes corresponding Graph/Chart) II-18
Table 16: Prevalence of Diabetes Mellitus in Europe (2012 &2030): Breakdown by Country and Age Group (in 000 People & %) II-19
Table 17: Prevalence of Diabetes Mellitus in South East Asia
(2012 & 2030): Breakdown by Country and Age Group (in '000
People & %) II-20
Table 18: Prevalence of Diabetes Mellitus in Western Asia,Pacific Regions (2012 & 2030): Breakdown by Country and AgeGroup (in 000 People & %) II-20
Table 19: Prevalence of Diabetes Mellitus in South & Central
America (2012 & 2030): Breakdown by Country and Age Group
(in 000 People & %) II-21
Table 20: Prevalence of Diabetes Mellitus in Africa (2012 &2030): Breakdown by Country and Age Group (in 000 People & %) II-22
Table 21: Prevalence of Diabetes Mellitus in Middle East &
North Africa (2012 & 2030): Breakdown by Country and Age
Group (in 000 People & %) II-23
Parental Nutrition Therapy Indicated for Diabetes Patients
with Non-functional Gastrointestinal Tract II-23
Global HIV Statistics II-24
Table 22: Global Summary of the AIDS Epidemic in 2011
(includes corresponding Graph/Chart) II-24
Some Significant HIV Statistics by Region (2011) II-24
Clinical Nutrition Therapies in Treating Malnutrition Offers
Significant Growth Opportunities II-25
Non-volitional Nutritional Support Therapy - Vital for
Combating Malnutrition during Hospitalization II-26
Trend towards Home Care to Boost Demand for Clinical Nutrition
Products II-26
Changing Health and Social Care Factors Favor Home Enteral
Feeding II-28
Rising Number of Premature Births Augurs Well for Clinical
Nutrition Products Market II-28
Preterm Birth Statistics from WHO II-29
Table 23: Percentage of Preterm Births by Region: 2012
(includes corresponding Graph/Chart) II-30
Table 24: Top Ten Countries with the Highest Number ofPreterm Births (2012) (includes corresponding Graph/Chart) II-31
Table 25: Top Ten Countries with the Highest Rates of
Preterm Births (per 100 Live Births): 2012 (includes
corresponding Graph/Chart) II-32
Demand for Personalized Medicine to Bode Well for Clinical
Nutrition Products Market II-32
Product Innovations Blur the Lines between Medicine and Foods II-33
Surging Demand for Omega-3 Fatty Acids-Fortified Clinical
Nutrition Products II-34
Technology Advances in Enteral Feeding Devices: Favorable
Prospects for Enteral Nutrition Market II-34
Rising Number of Pediatric Crohn's Disease Patients Fuels
Enteral Nutrition Market II-35
Pre-mixed IV Solutions: A Step towards Safer Medication Practices II-36
Growing Demand for Low-Cost Solutions for Parenteral Nutrition II-36
Rising Preference for Multi-Chamber Bags to Lower Cost of
Parenteral Nutrition Therapy II-37
Increasing Popularity of Intravenous Vitamin C for Cancer
Treatment II-37
Infection Control: A Prime Concern in Parenteral Nutrition II-37
Complacency of Hospitals & Worker/Patient Safety: A Key Issue II-38
Favorable Clinical Findings Strengthens Market Prospects for
Enteral Nutrition II-38
Rising Preference for Enteral Nutrition - A Threat to
Parenteral Nutrition Market II-39
Advantages and Disadvantages of Enteral Nutrition over
Parenteral Nutrition II-40
Major Challenges Confronting Medical Nutrition Products'
Marketers II-40
Safety and Nutrition of Infant Nutrition Products Tops
Priority Charts for Consumers II-41
Impact of Demographic and Socio-cultural Factors on Infant
Nutrition Market II-41
Barriers to Widespread Adoption of Clinical Nutrition Products II-42
Reasons for Not Prescribing Clinical Nutrition Products II-42
3. PRODUCT OVERVIEW II-43Clinical Nutrition II-43Advantages of Clinical Nutrition II-43Clinical Nutrition Products II-44Infant Nutrition II-44Important Characteristics of Infant Nutrition Formulas II-45Table 26: Nutrient Specifications for Infant Formulas (per100kcal) II-45List of Infant Nutrition Products II-46Human Milk Oligosaccharides II-47Prebiotics in Infant Nutrition II-47DHA and ARA II-48Nutrition Products for Preterm Infants II-48Premature Infant Formula II-48Transitional Formulas II-49Human Milk Fortifiers II-49Metabolic Infant Formulas II-49Follow-up or Follow-on Formulas II-49Enteral Administration of Infant Formulas in NeonatalIntensive Care and General Healthcare Settings II-49Nipple Feeding II-49Tube Feeding II-50Enteral Nutrition or Tube Feeding II-50Table 27: Daily Electrolyte Requirements for EnteralNutrition II-51
Table 28: Daily Trace Element Requirement for Enteral
Nutrition II-51
Table 29: Daily Vitamin Requirements for Enteral Nutrition II-52
Table 30: Daily Trace Element Requirements Enteral Nutrition
in Infants II-52
Table 31: Daily Vitamin Requirements for Enteral Nutritionin Infants II-52Enteral Nutrition by Age II-53Enteral Nutrition for Patients aged 21 and older II-53Enteral Nutrition for Patients Below 21 Years II-53Various Types of Enteral Feeding or Tube Feeding II-53What Constitutes Enteral Nutrition Diets? II-54Home-Made Diets II-54Commercial Enteral Formulas II-54Elemental Formulas II-54Oligomeric Formulas II-55Polymeric Formulas II-55Special Formulas II-55Pulmonary Formulas II-55Liver Formulas II-56Renal Formulas II-56Diabetes Formulas II-56Gastrointestinal Dysfunction Formulas II-56Immuno-modulatory Formulas II-57Enteral Nutrition in Patients with Acute Renal Failure (ARF) II-57Table 32: Nutritional Requirements in Patients with ARF II-57Enteral Nutrition in Conservatively Treated Patients withChronic Renal Failure (CRF) II-57Table 33: Recommendations for Protein Supply in Adult CRFPatients (in g/kgBW/day) II-58
Table 34: Mineral Requirements for Patients with CRF II-58
Enteral Nutrition in Haemodialysis Patients II-58
Enteral Nutrition in Chronic Ambulatory Peritoneal Dialysis
(CAPD) Patients II-58
Table 35: Recommendations for Protein and Energy Supply in
Adult Patients on Routine Hemodialysis and CAPD II-59
Table 36: Mineral Requirements of Patients on Haemodialysisand Chronic Ambulatory Peritoneal Dialysis II-59Complications of Enteral Feeding II-59Complications Associated with Enteral Tube Feeding II-60Parenteral Nutrition II-62Sources of Parenteral Solutions II-63Routes of Administration II-63Types of Parenteral Nutrition Solutions II-64Total Parenteral Nutrition (TPN) II-64Table 37: Daily Requirements for Total ParenteralNutrition (TPN) in Adults II-64Table 38: Daily Recommended Parenteral Nutritional Intakesfor Newborns II-65TPN Formulation II-66Partial Parenteral Nutrition (PPN) II-66Home Parenteral Nutrition II-66Parenteral Nutrition Formulations II-66Standard Solutions II-66Three-in-One Standard Bags II-67Two-in-one Standard Bags II-67Individual Solutions II-67Non-Standard Solutions II-67Classification of Parenteral Nutrition by Type of Nutrients II-67Amino Acids II-67Carbohydrates II-68Lipids II-68Minerals & Electrolytes II-68Table 39: Daily Electrolyte Requirements for ParenteralNutrition II-69Micronutrients II-69Vitamins II-69Table 40: Daily Vitamin Requirements for ParenteralNutrition II-70Trace Elements II-71Table 41: Daily Trace Element Requirement for ParenteralNutrition II-71Large and Small Volume Parenteral Solutions II-71Large Volume Parenteral (LVP) Solutions II-71Small Volume Parenteral (SVP) Solutions II-72IV Fat Emulsions - Enabling Maintenance of Bodyweight II-72
4. PRODUCT INNOVATIONS/INTRODUCTIONS II-73
Ingredion Europe Introduces UNI-PURE IMF 2332 and UNI-PURE IMF
8561 Infant Nutrition Products II-73
Fonterra China to Launch Self-Branded Infant Formula in China II-73
FDA Clears Fresenius Kabi for Emergency Import of
Injectionable TPN Drugs II-73
Marck Biosciences Receives MCC Approval for Pharma Products II-73
Restore Health Pharmacy Launches High Quality Nutritional
Supplement II-74
Inergetics Introduces Surgex Ready to Drink Nutritional Beverage II-74
Arla Foods Ingredients Introduces Revolutionary Whey Protein II-74
Nestlé Health Science Rolls Out SpikeRight® PLUS for Enteral
Safety II-74
Claris Receives USFDA Approval for Marketing Products in the US II-75
Baxter International Launches NUMETA Triple-Chamber IV
Nutrition System II-75
Science Based Health Introduces MacularProtect Omega 3
Companion and MacularProtect Complete Nutritional
Formulations II-75
Pfizer Launches GOLD Range of Nutrition Products for Children II-76
Nestlé Lanka Rolls Out NeslacExcella 1+ Infant Milk Formula II-76
Nestlé Introduces BabyNes Nutrition System for Toddlers and
Infants II-76
Baxter Launches OLIMEL Emulsion as Canada's First Triple-
Chamber Bag for Parenteral Nutrition II-77
B. Braun Rolls Out NuTRIflex® Omega II-77
PBM Products Introduces Bright Beginnings® NeoCare™ II-78
Fresenius Kabi Launches SmofKaviben II-78
Nutricia Introduces Neocate Nutra II-78
Wimm-Bill-Dann Offers life'sDHA & life'sARA™- Intregrated
Infant Formula II-78
Nestle Launches Infant Nutrition Milk Powder in China II-79
Abbott Introduces Similac Advance EarlyShield™ and Similac®
SimplePac™ II-79
5. RECENT INDUSTRY ACTIVITY II-80Nestle Health Science Purchases Pamlab II-80Danone Takes Over Stake in Happy Family II-80Aspen Acquires IP Rights in Infant Nutritional Businesses ofNestlé II-80Danone Completes Acquisition of Wockhardt's Nutrition Business II-81Satori Capital Acquires Longhorn Health Solutions II-81Abbott Nutrition Discontinues Enteral Device Business in theUS and Puerto Rico II-81Danone Recalls Infant-Formula Products in Asia II-81Hospira Recalls IV Electrolyte Solution II-82Depol Sp. z o.o. Hurtownia Farmaceutyczna Secures Contractfrom Samodzielny Publiczny Szpital Kliniczny II-82Nestle Acquires Pfizer Nutrition II-82Aperture Health Takes Over Triad Therapeutics II-82Nestlé Health Science Acquires Stake in Accera II-82B Braun Acquires Nutrichem II-83Mead Johnson Nutrition Enters into Joint Venture with Sancor II-83Abbott Plans Collaboration with Syngene for Nutrition R&D Unit II-83AarhusKarlshamn Expands Capacity to Produce InFat™ II-84Abbot Inaugurates Nutrition Production Facility in Ohio II-84BioGaia Enters into a Collaboration Agreement with Nestlé II-84Claris Lifesciences Enters into JV with Otsuka Pharma andMitsui for Indian Market II-85Ajinomoto, USAID and JICA Agency Ink MoU II-85B. Braun Establishes Pharmaceutical Plant in the US II-85Evolva Acquires Abunda Nutrition II-86Medical Australia and Pharmatel Frensius Kabi Ink OEMPartnership Agreement II-86Consorci de Salut i Atencio Social de Catalunya Bags SupplyContract from B. Braun Medical II-86Fresenius KABI Italia Obtains Supply Contract from ESTAV Sud II-86Baxter Secures Contract from ASL Milano 1 II-87FrieslandCampina Plans Capacity Expansion II-87Nestle HealthCare Establishes Manufacturing Unit to ProduceNutrition Products and Infant Formulae II-87Fresenius Kabi and Nutricia Belgique Obtain Contract from CHRDe La Citadelle II-87Fresenius Kabi Establishes Manufacturing Plant in Vietnam II-88Grifols to Set Up Form-Fill-Seal Production Lines forParenteral Solutions II-88Baxter International Signs Distribution Agreement with HanmiPharmaceutical II-88Hospira Enters into Agreements with Novation II-88Pfizer Takes Over Wyeth II-89Bristol-Myers Squibb Divests Stake in Mead Johnson Nutrition II-89Martek Biosciences and Ragasa Ink Agreement II-89Lactalis Nutrition Sante Signs Agreement with Martek Biosciences II-89Milk Powder Solutions Signs Agreement with Martek Biosciences II-89Beech Nut and Abbott Enter into Collaboration II-90Grupo Ricap Inks Agreement with Martek Biosciences II-90Abbott Nutrition Opens New Production Unit II-90Alticor and Metagenics Enter into Joint Venture II-90Hain Celestial and Hutchison China Meditech Enter into JointVenture II-90Hangzhou Minsheng Pharmaceutical and Choongwae Holdings InkAgreement II-91Bayshore Home Health Takes Over Coram Healthcare II-91Otsuka Pharmaceutical Acquires Nardobel II-91Glanbia Nutritionals Establishes Production Plant II-91Nestle Establishes Infant Nutrition Facility II-92Ventria Bioscience Increases Production of Lactoferrin II-92Fresenius Kabi Inks Agreement with Dabur Pharma II-92Abbott Recalls 2 Batches of Calcilo XD® Infant Formula II-92Nutritek Divests Dairy Business to Russagroprom II-93Hero Acquires Bledina Infant Nutrition License II-93BioGaia and Nestlé Nutrition Ink Agreement II-93
6. FOCUS ON SELECT GLOBAL PLAYERS II-94
Abbott Laboratories, Inc. (US) II-94
Abbott Nutrition (US) II-94
Ajinomoto Co., Inc. (Japan) II-94
American HomePatient, Inc. (US) II-95
Baxter International, Inc. (US) II-96
B. Braun Melsungen AG (Germany) II-97
Claris Lifesciences Ltd. (India) II-97
Groupe Danone (France) II-98
Nutricia North America (US) II-98
Fresenius Kabi AG (Germany) II-99
Hospira, Inc. (US) II-99
Mead Johnson Nutrition Company (US) II-100
List of Select Infant Nutrition Formula from Mead Johnson
Nutrition Company II-101
Meiji Co., Ltd. (Japan) II-101
Nestlé Health Science S.A (Switzerland) II-102
Nestlé HealthCare Nutrition (US) II-103
Otsuka Pharmaceutical Factory, Inc (Japan) II-103
Sino-Swed Pharmaceutical Corp, Ltd. (China) II-104
The H. J. Heinz Company (US) II-104
7. GLOBAL MARKET PERSPECTIVE II-105Table 42: World Recent Past, Current and Future Analysis forClinical Nutrition Products by Geographic Region - US, Canada,Japan, Europe, Asia-Pacific, Middle East/Africa and LatinAmerica Markets Independently Analyzed with Annual SalesFigures in US$ Million for Years 2010 through 2018 (includescorresponding Graph/Chart) II-105
Table 43: World Historic Review for Clinical Nutrition
Products by Geographic Region - US, Canada, Japan, Europe,
Asia-Pacific, Middle East/Africa and Latin America Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2004 through 2009 (includes corresponding
Graph/Chart) II-106
Table 44: World 15-Year Perspective for Clinical NutritionProducts by Geographic Region - Percentage Breakdown of DollarSales for US, Canada, Japan, Europe, Asia-Pacific, MiddleEast/ Africa and Latin America Markets for Years 2004, 2013and 2018 (includes corresponding Graph/Chart) II-107
Table 45: World Recent Past, Current and Future Analysis for
Enteral Nutrition Products by Geographic Region - US, Canada,
Japan, Europe, Asia-Pacific, Middle East/Africa and Latin
America Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) II-108
Table 46: World Historic Review for Enteral Nutrition Productsby Geographic Region - US, Canada, Japan, Europe,Asia-Pacific, Middle East/Africa and Latin America MarketsIndependently Analyzed with Annual Sales Figures in US$Million for Years 2004 through 2009 (includes correspondingGraph/Chart) II-109
Table 47: World 15-Year Perspective for Enteral Nutrition
Products by Geographic Region - Percentage Breakdown of Dollar
Sales for US, Canada, Japan, Europe, Asia-Pacific, Middle
East/ Africa and Latin America Markets for Years 2004, 2013
and 2018 (includes corresponding Graph/Chart) II-110
Table 48: World Recent Past, Current and Future Analysis forInfant Nutrition Products by Geographic Region - US, Canada,Japan, Europe, Asia-Pacific, Middle East/Africa and LatinAmerica Markets Independently Analyzed with Annual SalesFigures in US$ Million for Years 2010 through 2018 (includescorresponding Graph/Chart) II-111
Table 49: World Historic Review for Infant Nutrition Products
by Geographic Region - US, Canada, Japan, Europe,
Asia-Pacific, Middle East/Africa and Latin America Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2004 through 2009 (includes corresponding
Graph/Chart) II-112
Table 50: World 15-Year Perspective for Infant NutritionProducts by Geographic Region - Percentage Breakdown of DollarSales for US, Canada, Japan, Europe, Asia-Pacific, MiddleEast/ Africa and Latin America Markets for Years 2004, 2013and 2018 (includes corresponding Graph/Chart) II-113
Table 51: World Recent Past, Current and Future Analysis for
Parenteral Nutrition Products by Geographic Region - US,
Canada, Japan, Europe, Asia-Pacific, Middle East/Africa and
Latin America Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) II-114
Table 52: World Historic Review for Parenteral NutritionProducts by Geographic Region - US, Canada, Japan, Europe,Asia-Pacific, Middle East/ Africa and Latin America MarketsIndependently Analyzed with Annual Sales Figures in US$Million for Years 2004 through 2009 (includes correspondingGraph/Chart) II-115
Table 53: World 15-Year Perspective for Parenteral Nutrition
Products by Geographic Region - Percentage Breakdown of Dollar
Sales for US, Canada, Japan, Europe, Asia-Pacific, Middle
East/Africa and Latin America Markets for Years 2004, 2013 and
2018 (includes corresponding Graph/Chart) II-116
III. MARKET
1. THE UNITED STATES III-1
A.Market Analysis III-1
Clinical Nutrition Products Market in a Capsule III-1
Rapidly Ageing Demographics: A Major Driving Factor III-1
Table 54: North American Elderly Population by Age Group
(1975-2050) (includes corresponding Graph/Chart) III-2
Rising Incidences of Chronic Diseases Enhance Need for
Clinical Nutrition Products III-3
Cancer Statistics in the US III-3
Table 55: New Cancer Cases in the US by Gender and
Affected Site (2013) III-4
Prevalence of Diabetes Mellitus in North America III-5
Table 56: Prevalence of Diabetes Mellitus in North
America: 2012 (includes corresponding Graph/Chart) III-5
Table 57: North America Incidence of Type 1 Diabetes inChildren (2012) (includes corresponding Graph/Chart) III-6An Insight into Infant Nutrition Market in the US III-6Rising Number of Premature Births Augurs Well for MarketGrowth III-6Table 58: US Pre-term Birth Statistics (2012) III-7Strategic Innovations to Buoy Consumer Demand III-8Human Breast Milk-Like Infant Formulas to Gain Popularity III-8A Highly Concentrated Marketplace III-9Table 59: Leading Infant Formula (Powder) Manufacturers inthe US (2012): Percentage Share Breakdown of Value Salesfor Mead Johnson Nutrition Co, Abbott Nutrition, NestléHealthcare Nutrition, Gerber Products Co, Private Labeland Others (includes corresponding Graph/Chart) III-9
Table 60: Leading Infant Formula Brands in the US (2012):
Percentage Share Breakdown of Value Sales for Enfamil
Premium, Similac Advance, Similac Sensitive, Enfamil
Gentlease, Gerber Good Start Gentle Plus, Gerber Good
Start Gentle, Similac Advance Early Shield, Private label
and Others (includes corresponding Graph/Chart) III-10
WIC Contract and the Infant Formula Rebate Program III-10
WIC's Infant Formula Rebate Program III-11
Enteral Nutrition Market III-11
Home Healthcare Fuels Demand for Home Enteral Nutrition
Products III-12
Enteral Nutrition Therapy to Treat Adult Malnutrition:
Opportunities for Growth III-12
Reimbursement Scenario for Enteral Nutrition Therapy III-13
ENT Coverage under Part A III-13
ENT Coverage under Part B III-14
Reimbursements for Enteral Nutrients III-15
Parenteral Nutrition Market: An Overview III-15
Medicare Coverage for Parenteral Nutrition Therapy III-15
Reimbursement Regulations to Hamper Market Growth III-16
Shift towards Enteral Nutrition Therapies - A Threat to the
US Parenteral Nutrition Market III-17
Advantages and Disadvantages of Enteral Nutrition over
Parenteral Nutrition III-17
A.S.P.E.N. Practice Guidelines for Parenteral Nutrition III-17
A.S.P.E.N. Guidelines for Parenteral Nutrition (as of 2004) III-18
Impact of Patient Protection and Affordable Care Act on IV
Solutions Market III-19
Product Launches III-20
Strategic Corporate Developments III-22
Key Players III-26
B.Market Analytics III-32
Table 61: US Recent Past, Current and Future Analysis for
Clinical Nutrition Products by Product Type - Enteral
Nutrition, Infant Nutrition, and Parenteral Nutrition
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-32
Table 62: US Historic Review for Clinical Nutrition Productsby Product Type - Enteral Nutrition, Infant Nutrition, andParenteral Nutrition Markets Independently Analyzed withAnnual Sales Figures in US$ Million for Years 2004 through2009 (includes corresponding Graph/Chart) III-33
Table 63: US 15-Year Perspective for Clinical Nutrition
Products by Product Type - Percentage Breakdown of Dollar
Sales for Enteral Nutrition, Infant Nutrition, and
Parenteral Nutrition Markets for Years 2004, 2013 and 2018
(includes corresponding Graph/Chart) III-34
2. CANADA III-35A.Market Analysis III-35Outlook III-35Rising Incidence of Chronic Diseases: A Major Growth Driver III-35Table 64: New Cancer Cases in Canada by Gender and AffectedSite (2012) (includes corresponding Graph/Chart) III-36
Table 65: New Cancer Cases in Canada by Province (2012)
(includes corresponding Graph/Chart) III-37
Table 66: New Cancer Cases in Canada by Age Group andGender (2012) (includes corresponding Graph/Chart) III-38
Table 67: Prevalence of Diabetes Mellitus in Canada (2012)
(includes corresponding Graph/Chart) III-38
An Overview of Infant Formula Market in Canada III-39
Table 68: Leading Players in the Canadian Baby Milk Market
(2012): Percentage Share Breakdown in Value Terms for
Abbott, Mead Johnson, Nestle and Others (includes
corresponding Graph/Chart) III-39
Product Launch III-40
B.Market Analytics III-41
Table 69: Canadian Recent Past, Current and Future Analysis
for Clinical Nutrition Products by Product Type - Enteral
Nutrition, Infant Nutrition, and Parenteral Nutrition
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-41
Table 70: Canadian Historic Review for Clinical NutritionProducts by Product Type - Enteral Nutrition, InfantNutrition, and Parenteral Nutrition Markets IndependentlyAnalyzed with Annual Sales Figures in US$ Million for Years2004 through 2009 (includes corresponding Graph/Chart) III-42
Table 71: Canadian 15-Year Perspective for Clinical
Nutrition Products by Product Type - Percentage Breakdown of
Dollar Sales for Enteral Nutrition, Infant Nutrition, and
Parenteral Nutrition Markets for Years 2004, 2013 and 2018
(includes corresponding Graph/Chart) III-43
3. JAPAN III-44A.Market Analysis III-44Outlook III-44Rising Incidence of Chronic Diseases - A Prime Growth Driver III-44Table 72: Prevalence of Diabetes Mellitus in Japan (2012 &2030) (includes corresponding Graph/Chart) III-45Parenteral Nutrition Market: An Overview III-45Key Players III-46B.Market Analytics III-48Table 73: Japanese Recent Past, Current and Future Analysisfor Clinical Nutrition Products by Product Type - EnteralNutrition, Infant Nutrition, and Parenteral NutritionMarkets Independently Analyzed with Annual Sales Figures inUS$ Million for Years 2010 through 2018 (includescorresponding Graph/Chart) III-48
Table 74: Japanese Historic Review for Clinical Nutrition
Products by Product Type - Enteral Nutrition, Infant
Nutrition, and Parenteral Nutrition Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2004 through 2009 (includes corresponding Graph/Chart) III-49
Table 75: Japanese 15-Year Perspective for ClinicalNutrition Products by Product Type - Percentage Breakdown ofDollar Sales for Enteral Nutrition, Infant Nutrition, andParenteral Nutrition Markets for Years 2004, 2013 and 2018(includes corresponding Graph/Chart) III-50
4. EUROPE III-51
A.Market Analysis III-51
Outlook III-51
Debt Crisis in Europe Affects Healthcare Industry III-51
European Healthcare System: In a State of Transition? III-51
Ageing Population to Drive Demand for Clinical Nutrition
Products Market III-52
Table 76: Population Breakup by Age Group for Select
European Countries: 2012 (as a Percentage of Total
Population) (includes corresponding Graph/Chart) III-53
An Overview of Enteral Feeding Market in Europe III-53
Prospering Enteral Nutrition Market: New Avenues for
Ingredient Suppliers III-54
Surging Interest in Home Healthcare: Gains for Enteral
Nutrition Market III-54
Infant Nutrition Market III-55
Increasing Preterm Births Propel Market Growth III-55
Competitive Landscape III-55
Table 77: Leading Players in Eastern Europe Infant Formula
Market (2012): Percentage Share Breakdown of Value Sales
Groupe Danone, Nestle SA, Hipp GmbH & Co Vertrieb KG and
Others (includes corresponding Graph/Chart) III-55
Table 78: Leading Players in Western Europe Infant FormulaMarket (2012): Percentage Share Breakdown of Value Salesfor Danone Groupe, Nestle SA, Lactalis Groupe and Others(includes corresponding Graph/Chart) III-56The EC Directive on Infant Formulae and Follow-on Formulae III-56FSA's Control on Infant Formulas and Follow-on FormulaAdvertisements III-57B.Market Analytics III-58Table 79: European Recent Past, Current and Future Analysisfor Clinical Nutrition Products by Geographic Region -France, Germany, Italy, UK, Spain, Russia and Rest of EuropeMarkets Independently Analyzed with Annual Sales Figures inUS$ Million for Years 2010 through 2018 (includescorresponding Graph/Chart) III-58
Table 80: European Historic Review for Clinical Nutrition
Products by Geographic Region - France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2004 through 2009 (includes corresponding Graph/Chart) III-59
Table 81: European 15-Year Perspective for ClinicalNutrition Products by Geographic Region - PercentageBreakdown of Dollar Sales for France, Germany, Italy, UK,Spain, Russia and Rest of Europe Markets for Years 2004,2013 and 2018 (includes corresponding Graph/Chart) III-60
Table 82: European Recent Past, Current and Future Analysis
for Clinical Nutrition Products by Product Type - Enteral
Nutrition, Infant Nutrition, and Parenteral Nutrition
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-61
Table 83: European Historic Review for Clinical NutritionProducts by Product Type - Enteral Nutrition, InfantNutrition, and Parenteral Nutrition Markets IndependentlyAnalyzed with Annual Sales Figures in US$ Million for Years2004 through 2009 (includes corresponding Graph/Chart) III-62
Table 84: European 15-Year Perspective for Clinical
Nutrition Products by Product Type - Percentage Breakdown of
Dollar Sales for Enteral Nutrition, Infant Nutrition, and
Parenteral Nutrition Markets for Years 2004, 2013 and 2018
(includes corresponding Graph/Chart) III-63
4a. FRANCE III-64A.Market Analysis III-64Outlook III-64Groupe Danone - A Key Player III-64B.Market Analytics III-65Table 85: French Recent Past, Current and Future Analysisfor Clinical Nutrition Products by Product Type - EnteralNutrition, Infant Nutrition, and Parenteral NutritionMarkets Independently Analyzed with Annual Sales Figures inUS$ Million for Years 2010 through 2018 (includescorresponding Graph/Chart) III-65
Table 86: French Historic Review for Clinical Nutrition
Products by Product Type - Enteral Nutrition, Infant
Nutrition, and Parenteral Nutrition Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2004 through 2009 (includes corresponding Graph/Chart) III-66
Table 87: French 15-Year Perspective for Clinical NutritionProducts by Product Type - Percentage Breakdown of DollarSales for Enteral Nutrition, Infant Nutrition, andParenteral Nutrition Markets for Years 2004, 2013 and 2018(includes corresponding Graph/Chart) III-67
4b. GERMANY III-68
A.Market Analysis III-68
Outlook III-68
An Overview of the Infant Nutrition Market III-68
Strategic Corporate Developments III-68
Key Players III-69
B.Market Analytics III-71
Table 88: German Recent Past, Current and Future Analysis
for Clinical Nutrition Products by Product Type - Enteral
Nutrition, Infant Nutrition, and Parenteral Nutrition
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-71
Table 89: German Historic Review for Clinical NutritionProducts by Product Type - Enteral Nutrition, InfantNutrition, and Parenteral Nutrition Markets IndependentlyAnalyzed with Annual Sales Figures in US$ Million for Years2004 through 2009 (includes corresponding Graph/Chart) III-72
Table 90: German 15-Year Perspective for Clinical Nutrition
Products by Product Type - Percentage Breakdown of Dollar
Sales for Enteral Nutrition, Infant Nutrition, and
Parenteral Nutrition Markets for Years 2004, 2013 and 2018
(includes corresponding Graph/Chart) III-73
4c. ITALY III-74A.Market Analysis III-74Outlook III-74Infant Formula Market: Leading Players III-74Table 91: Leading Players in the Italian Infant FormulaMarket (2012): Percentage Share Breakdown of Value Salesfor Danone, Heinz, Nestle and Others (includescorresponding Graph/Chart) III-74Strategic Corporate Developments III-75B.Market Analytics III-75Table 92: Italian Recent Past, Current and Future Analysisfor Clinical Nutrition Products by Product Type - EnteralNutrition, Infant Nutrition, and Parenteral NutritionMarkets Independently Analyzed with Annual Sales Figures inUS$ Million for Years 2010 through 2018 (includescorresponding Graph/Chart) III-75
Table 93: Italian Historic Review for Clinical Nutrition
Products by Product Type - Enteral Nutrition, Infant
Nutrition, and Parenteral Nutrition Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2004 through 2009 (includes corresponding Graph/Chart) III-76
Table 94: Italian 15-Year Perspective for Clinical NutritionProducts by Product Type - Percentage Breakdown of DollarSales for Enteral Nutrition, Infant Nutrition, andParenteral Nutrition Markets for Years 2004, 2013 and 2018(includes corresponding Graph/Chart) III-77
4d. THE UNITED KINGDOM III-78
A.Market Analysis III-78
Outlook III-78
Infant Formula Market: Competition III-78
Table 95: Leading Players in the UK Infant Formula Market
(2012): Percentage Share Breakdown of Value Sales for
Danone, Nestle and Others (includes corresponding
Graph/Chart) III-78
Vitacare - A Key Player III-79
B.Market Analytics III-79
Table 96: UK Recent Past, Current and Future Analysis for
Clinical Nutrition Products by Product Type - Enteral
Nutrition, Infant Nutrition, and Parenteral Nutrition
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-79
Table 97: UK Historic Review for Clinical Nutrition Productsby Product Type - Enteral Nutrition, Infant Nutrition, andParenteral Nutrition Markets Independently Analyzed withAnnual Sales Figures in US$ Million for Years 2004 through2009 (includes corresponding Graph/Chart) III-80
Table 98: UK 15-Year Perspective for Clinical Nutrition
Products by Product Type - Percentage Breakdown of Dollar
Sales for Enteral Nutrition, Infant Nutrition, and
Parenteral Nutrition Markets for Years 2004, 2013 and 2018
(includes corresponding Graph/Chart) III-81
4e. SPAIN III-82A.Market Analysis III-82Outlook III-82Strategic Corporate Developments III-82B.Market Analytics III-83Table 99: Spanish Recent Past, Current and Future Analysisfor Clinical Nutrition Products by Product Type - EnteralNutrition, Infant Nutrition, and Parenteral NutritionMarkets Independently Analyzed with Annual Sales Figures inUS$ Million for Years 2010 through 2018 (includescorresponding Graph/Chart) III-83
Table 100: Spanish Historic Review for Clinical Nutrition
Products by Product Type - Enteral Nutrition, Infant
Nutrition, and Parenteral Nutrition Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2004 through 2009 (includes corresponding Graph/Chart) III-84
Table 101: Spanish 15-Year Perspective for ClinicalNutrition Products by Product Type - Percentage Breakdown ofDollar Sales for Enteral Nutrition, Infant Nutrition, andParenteral Nutrition Markets for Years 2004, 2013 and 2018(includes corresponding Graph/Chart) III-85
4f. RUSSIA III-86
Market Analysis III-86
Table 102: Russian Recent Past, Current and Future Analysis
for Clinical Nutrition Products by Product Type - Enteral
Nutrition, Infant Nutrition, and Parenteral Nutrition
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-86
Table 103: Russian Historic Review for Clinical NutritionProducts by Product Type - Enteral Nutrition, InfantNutrition, and Parenteral Nutrition Markets IndependentlyAnalyzed with Annual Sales Figures in US$ Million for Years2004 through 2009 (includes corresponding Graph/Chart) III-87
Table 104: Russian 15-Year Perspective for Clinical
Nutrition Products by Product Type - Percentage Breakdown of
Dollar Sales for Enteral Nutrition, Infant Nutrition, and
Parenteral Nutrition Markets for Years 2004, 2013 and 2018
(includes corresponding Graph/Chart) III-88
4g. REST OF EUROPE III-89A.Market Analysis III-89Outlook III-89Infant Formula Market: Key Statistics III-89Table 105: Leading Players in the Ireland Infant FormulaMarket (2012): Percentage Share Breakdown of Value Salesfor Danone, Nestle SA, Heinz and Others (includescorresponding Graph/Chart) III-89
Table 106: Leading Players in the Turkish Infant Formula
Market (2012): Percentage Share Breakdown of Value Sales
for Danone, Nestle and Others (includes corresponding
Graph/Chart) III-89
Product Launches III-90
Strategic Corporate Developments III-91
Nestlé Health Science S.A (Switzerland) - A Key Player III-94
B.Market Analytics III-95
Table 107: Rest of Europe Recent Past, Current and Future
Analysis for Clinical Nutrition Products by Product Type -
Enteral Nutrition, Infant Nutrition, and Parenteral
Nutrition Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-95
Table 108: Rest of Europe Historic Review for ClinicalNutrition Products by Product Type - Enteral Nutrition,Infant Nutrition, and Parenteral Nutrition MarketsIndependently Analyzed with Annual Sales Figures in US$Million for Years 2004 through 2009 (includes correspondingGraph/Chart) III-96
Table 109: Rest of Europe 15-Year Perspective for Clinical
Nutrition Products by Product Type - Percentage Breakdown of
Dollar Sales for Enteral Nutrition, Infant Nutrition, and
Parenteral Nutrition Markets for Years 2004, 2013 and 2018
(includes corresponding Graph/Chart) III-97
5. ASIA-PACIFIC III-98A.Market Analysis III-98Outlook III-98Infant Formula Market: Competition III-98Table 110: Leading Players in the Asian Infant FormulaMarket (2012): Percentage Share Breakdown of Value Salesfor Nestle SA, Groupe Danone, Mead Johnson and Others(includes corresponding Graph/Chart) III-98B.Market Analytics III-99Table 111: Asia-Pacific Recent Past, Current and FutureAnalysis for Clinical Nutrition Products by GeographicRegion - China, India and Rest of Asia-Pacific MarketsIndependently Analyzed with Annual Sales Figures in US$Million for Years 2010 through 2018 (includes correspondingGraph/Chart) III-99
Table 112: Asia-Pacific Historic Review for Clinical
Nutrition Products by Geographic Region - China, India and
Rest of Asia-Pacific Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2004 through
2009 (includes corresponding Graph/Chart) III-100
Table 113: Asia-Pacific 15-Year Perspective for ClinicalNutrition Products by Geographic Region - PercentageBreakdown of Dollar Sales for China, India and Rest ofAsia-Pacific Markets for Years 2004, 2013 and 2018 (includescorresponding Graph/Chart) III-101
Table 114: Asia-Pacific Recent Past, Current and Future
Analysis for Clinical Nutrition Products by Product Type -
Enteral Nutrition, Infant Nutrition, and Parenteral
Nutrition Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-102
Table 115: Asia-Pacific Historic Review for ClinicalNutrition Products by Product Type - Enteral Nutrition,Infant Nutrition, and Parenteral Nutrition MarketsIndependently Analyzed with Annual Sales Figures in US$Million for Years 2004 through 2009 (includes correspondingGraph/Chart) III-103
Table 116: Asia-Pacific 15-Year Perspective for Clinical
Nutrition Products by Product Type - Percentage Breakdown of
Dollar Sales for Enteral Nutrition, Infant Nutrition, and
Parenteral Nutrition Markets for Years 2004, 2013 and 2018
(includes corresponding Graph/Chart) III-104
5a. CHINA III-105A.Market Analysis III-105Outlook III-105Infant Formula Market: A Review III-105Table 117: Infant Formula Market in China (2012):Percentage Share Breakdown of Value Sales by Price Category(includes corresponding Graph/Chart) III-105Consolidation to Strengthen Infant Formula Industry III-106China Slaps Fines on Six Infant Formula Companies forPrice-Fixing III-106Companies Lower Prices of Infant Formula Following Anti-Monopoly Probe III-106Key Challenges Facing Infant Formula Market III-107Increasing Competition from Imported Infant Nutrition Formula III-107Birth Rate III-107Need to Regain Consumer Confidence III-107Others III-107Competition in the Chinese Infant Nutrition Market III-107Table 118: Leading Players in the Ch
To order this report: Global Clinical Nutrition Products Industry http://www.reportlinker.com/p01375125/Global-Clinical-Nutrition-Products-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pharmaceutical
__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001
SOURCE Reportlinker
Share this article